Therapeutics

• interior-furniture

Viking Therapeutics: The Obesity Drugs Gold Rush Is Far From Over

1월 3, 2026

📋 Viking Therapeutics: The Obesity Drugs Gold Rush Is...

Read More

• financial-banking

Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock?

1월 2, 2026

📋 Is Cidara Therapeutics a Buy After HighVista Strategies...

Read More

• 자유게시판

TG Therapeutics: What Wall Street Isn’t Telling You

12월 30, 2025

📋 TG Therapeutics: What Wall Street Isn’t Telling You...

Read More

• education-academy

Leerink Partners downgrades Amicus Therapeutics stock on BioMarin acquisition

12월 29, 2025

📋 Leerink Partners downgrades Amicus Therapeutics stock on BioMarin...

Read More

• consulting-business

Third Time’s The Charm: Outlook Therapeutics Lytenava Heads To FDA, Again

12월 29, 2025

📋 Third Time’s The Charm: Outlook Therapeutics Lytenava Heads...

Read More

• shopping-retail

Why Travere Therapeutics Stock Popped by Nearly 14% on Wednesday

12월 25, 2025

📋 Why Travere Therapeutics Stock Popped by Nearly 14%...

Read More

• consulting-business

Nektar Therapeutics(NKTR), 원형 탈모증에 대한 레즈페갈데스류킨에 대한 REZOLVE-AA 2b상 연구의 주요 결과 논의 – 슬라이드쇼

12월 17, 2025

📋 Nektar Therapeutics(NKTR), 원형 탈모증에 대한 레즈페갈데스류킨에 대한 REZOLVE-AA...

Read More

• financial-banking

Amicus Therapeutics stock hits 52-week high at 10.61 USD

12월 12, 2025

📋 Amicus Therapeutics stock hits 52-week high at 10.61...

Read More

• food-dining

양식 8K Ovid Therapeutics Inc 대상: 12월 11일

12월 11, 2025

📋 양식 8K Ovid Therapeutics Inc 대상: 12월 11일...

Read More

• financial-banking

Fulcrum Therapeutics launches $150 million common stock offering

12월 8, 2025

📋 Fulcrum Therapeutics launches $150 million common stock offering...

Read More